JENEE NGUYEN: Open Payments
NPI 1255754404 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 48 payments from 14 companies in 2025. Trend: 2023 $1,265 · 2024 $1,345 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $265 |
| Lilly USA, LLC | 10 | $202 |
| Novo Nordisk Inc | 9 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $113 |
| Insulet Corporation | 3 | $77 |
| Sequel Med Tech, LLC | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Dexcom, Inc. | 2 | $40 |
| Tandem Diabetes Care, Inc. | 1 | $32 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
Products named: FREESTYLE LIBRE 3, Ozempic, MOUNJARO, Kerendia, Omnipod, TWIIST, JARDIANCE, FARXIGA.
Industry payments across LA — which companies pay providers there.
